Ekkehard Glimm, Ph.D., is biometrical fellow at Novartis Pharma in Basel, Switzerland. He joined Novartis in 2005, working first in oncology biostatistics and in the statistical methodology group since 2006. He is supporting clinical teams with the design and analysis of clinical trials across
all therapeutic areas in Novartis. Since 2014, he is also an adjunct professor (‘Privatdozent’) for biostatistics in the medical faculty of the University of Magdeburg, Germany.
Ekkehard has a background in multivariate statistics. More recently, Ekkehard’s work has focused on adaptive clinical trial designs, methods for multiple endpoints in clinical trials and analysis of rare adverse events in clinical projects. Ekkehard has authored and co-authored around 40 papers published in peer-reviewed scientific journals.